treatment of high risk nmibc in era of bcg shortage - empire urology lecture series
Published 4 years ago • 877 plays • Length 51:36Download video MP4
Download video MP3
Similar videos
-
57:13
risk stratified management of nmibc - empire urology lecture series
-
15:48
managing nmibc in the bcg shortage era
-
51:32
bladder preservation strategies for mibc - empire urology lecture series
-
57:35
muscle invasive bladder cancer - empire urology lecture series
-
59:16
nmibc guidelines, cystectomy and metabolic derangement's - empire urology in service review
-
38:23
new standards of therapy for advanced urothelial carcinoma - empire urology lecture series
-
46:38
management of upper tract urothelial carcinoma - empire urology lecture series
-
43:50
urowebinar: new treatments development in nmibc
-
1:01:10
urowebinar: patient stratification and risk related treatment of nmibc
-
53:47
immunotherapy for metastatic rcc - empire urology lecture series
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
9:12
immunotherapy for nmibc: emerging and expanding indications
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
19:31
adaptive immune resistance to intravesical bcg in nmibc: bcg-unresponsive clinical trials
-
51:51
beyond bcg in non-muscle invasive bladder cancer
-
3:20
case 1: treatments for nmibc refractory to bcg
-
19:31
second line bladder cancer therapies when first line treatments fail
-
50:41
management of bcg-unresponsive non-muscle invasive bladder cancer